S&P 500   4,532.39 (+0.28%)
DOW   35,575.10 (+0.33%)
QQQ   374.60 (-0.23%)
AAPL   148.94 (+0.12%)
MSFT   307.24 (-0.32%)
FB   340.56 (+0.17%)
GOOGL   2,835.35 (-1.03%)
TSLA   863.72 (-0.06%)
AMZN   3,417.82 (-0.76%)
NVDA   220.73 (-0.97%)
BABA   177.58 (+0.33%)
NIO   39.67 (-0.90%)
CGC   14.15 (-1.32%)
GE   105.72 (+0.95%)
AMD   116.26 (-0.06%)
MU   68.25 (+1.01%)
T   25.92 (+1.29%)
F   16.05 (+4.09%)
ACB   7.64 (+2.55%)
DIS   170.50 (-0.40%)
PFE   42.74 (+1.54%)
BA   216.20 (+0.11%)
AMC   40.96 (+0.39%)
S&P 500   4,532.39 (+0.28%)
DOW   35,575.10 (+0.33%)
QQQ   374.60 (-0.23%)
AAPL   148.94 (+0.12%)
MSFT   307.24 (-0.32%)
FB   340.56 (+0.17%)
GOOGL   2,835.35 (-1.03%)
TSLA   863.72 (-0.06%)
AMZN   3,417.82 (-0.76%)
NVDA   220.73 (-0.97%)
BABA   177.58 (+0.33%)
NIO   39.67 (-0.90%)
CGC   14.15 (-1.32%)
GE   105.72 (+0.95%)
AMD   116.26 (-0.06%)
MU   68.25 (+1.01%)
T   25.92 (+1.29%)
F   16.05 (+4.09%)
ACB   7.64 (+2.55%)
DIS   170.50 (-0.40%)
PFE   42.74 (+1.54%)
BA   216.20 (+0.11%)
AMC   40.96 (+0.39%)
S&P 500   4,532.39 (+0.28%)
DOW   35,575.10 (+0.33%)
QQQ   374.60 (-0.23%)
AAPL   148.94 (+0.12%)
MSFT   307.24 (-0.32%)
FB   340.56 (+0.17%)
GOOGL   2,835.35 (-1.03%)
TSLA   863.72 (-0.06%)
AMZN   3,417.82 (-0.76%)
NVDA   220.73 (-0.97%)
BABA   177.58 (+0.33%)
NIO   39.67 (-0.90%)
CGC   14.15 (-1.32%)
GE   105.72 (+0.95%)
AMD   116.26 (-0.06%)
MU   68.25 (+1.01%)
T   25.92 (+1.29%)
F   16.05 (+4.09%)
ACB   7.64 (+2.55%)
DIS   170.50 (-0.40%)
PFE   42.74 (+1.54%)
BA   216.20 (+0.11%)
AMC   40.96 (+0.39%)
S&P 500   4,532.39 (+0.28%)
DOW   35,575.10 (+0.33%)
QQQ   374.60 (-0.23%)
AAPL   148.94 (+0.12%)
MSFT   307.24 (-0.32%)
FB   340.56 (+0.17%)
GOOGL   2,835.35 (-1.03%)
TSLA   863.72 (-0.06%)
AMZN   3,417.82 (-0.76%)
NVDA   220.73 (-0.97%)
BABA   177.58 (+0.33%)
NIO   39.67 (-0.90%)
CGC   14.15 (-1.32%)
GE   105.72 (+0.95%)
AMD   116.26 (-0.06%)
MU   68.25 (+1.01%)
T   25.92 (+1.29%)
F   16.05 (+4.09%)
ACB   7.64 (+2.55%)
DIS   170.50 (-0.40%)
PFE   42.74 (+1.54%)
BA   216.20 (+0.11%)
AMC   40.96 (+0.39%)
OTCMKTS:ACGJ

ACI Global Stock Forecast, Price & News

$0.0050
0.00 (0.00 %)
(As of 10/19/2021 12:00 AM ET)
Add
Compare
Today's Range
$0.01
▼
$0.01
50-Day Range
$0.01
▼
$0.01
52-Week Range
$0.01
▼
$0.01
VolumeN/A
Average Volume4 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
Beta2.22
View Price History Chart DataSkip Price History Chart
30 days | 90 days | 365 days | Advanced Chart
Receive ACGJ News and Ratings via Email

Sign-up to receive the latest news and ratings for ACI Global and its competitors with MarketBeat's FREE daily newsletter.


ACI Global logo

About ACI Global

ACI Global Corp.'s drug candidates are proprietary synthetic and natural peptides (small proteins). Antecedents for these compounds occur in nature as part of the immune system of animals, insects and plants. Generally, the peptides bind to and kill harmful microorganisms and cancer cells. P113D, the Company's product candidate for cystic fibrosis, has been awarded Orphan Drug designation by the United States Food and Drug Administration (FDA). The Company's peptide technology can also be used to prevent serious damage to crops caused by fungal and bacterial diseases.

Headlines

No headlines for this company have been tracked by MarketBeat.com

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Medical laboratories
Sub-Industry
N/A
Sector
Industrial Products
Current Symbol
OTCMKTS:ACGJ
Previous Symbol
CUSIP
N/A
CIK
N/A
Web
N/A
Phone
N/A
Employees
N/A
Year Founded
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Net Income
N/A
Net Margins
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Price-To-Earnings

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A

Miscellaneous

Outstanding Shares
N/A
Market Cap
N/A
Next Earnings Date
N/A
Optionable
Not Optionable

MarketRank™

Overall MarketRank™

0.33 out of 5 stars

Analyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.0 5 -4 -3 -2 -1 -












ACI Global (OTCMKTS:ACGJ) Frequently Asked Questions

What stocks does MarketBeat like better than ACI Global?

Wall Street analysts have given ACI Global a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but ACI Global wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

What is ACI Global's stock symbol?

ACI Global trades on the OTCMKTS under the ticker symbol "ACGJ."

How do I buy shares of ACI Global?

Shares of ACGJ can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is ACI Global's stock price today?

One share of ACGJ stock can currently be purchased for approximately $0.01.


This page was last updated on 10/20/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here

As Featured By:

MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

Twitter Facebook StockTwits

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.